Spinal cord injury

Terebellum, Global Healthcare and Specialty Pharmacy Solutions Company Announces Partnership with NeurosolvTherapeutics

Retrieved on: 
Tuesday, October 4, 2022
Managed Care, Software, Other Health, Professional Services, Data Management, Venture Capital, Technology, Health Technology, Data Analytics, Biotechnology, Finance, Health, Consulting, Solution, Science, Consultant, Spinal cord injury, Research, Disease, Knowledge, Nervous system, Multimedia, Specialty pharmacy, Lynch, Glia, List of life sciences, Partnership, Health care, Spinal cord, Company, Patient, Travel, EMA, Management, Hospital

Terebellums services include strategic guidance in the pre-commercialization stage, market access expertise, and supply chain logistics including distribution and fulfillment.

Key Points: 
  • Terebellums services include strategic guidance in the pre-commercialization stage, market access expertise, and supply chain logistics including distribution and fulfillment.
  • Terebellum is an Ireland and UK based subsidiary of AscellaHealth representing our global footprint throughout Europe.
  • Terebellums leadership team has the deep bench expertise needed to provide a consultative approach for branded specialty products to be brought to market successfully.
  • Visit www.terebellumltd.com
    The AscellaHealth Family of Companies, comprised of AscellaHealth and subsidiaries Optime Care and Terebellum , is a global Healthcare and Specialty Pharmacy solutions organization serving specialty and rare disease patients, payers, life sciences manufacturers and providers with solutions addressing the unmet needs in this dynamic marketplace.

Australia Regenerative Medicine Market Report 2022: Expanding Healthcare Infrastructure and Increasing Evolution in the Pharmaceutical Sector Drives Sector - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 29, 2022
Health, Stem Cells, Research, Pharmaceutical, Science, Biotechnology, Regenerative medicine, Osteoporosis, Engineering, CVD, CTM, Spinal cord injury, Parkinson's disease, Application, Growth, Tissue engineering, Health, CRC, Regeneration, Degenerative disease, Tissue, Research, Cancer, Alzheimer's disease, CAGR, Pharmaceutical industry, Medical imaging, Science

Australia regenerative medicine market is projected to grow at a significant CAGR during the forecast period, 2023-2027.

Key Points: 
  • Australia regenerative medicine market is projected to grow at a significant CAGR during the forecast period, 2023-2027.
  • The market growth can be attributed to the expanding healthcare infrastructure and increasing evolution in the pharmaceutical sector to design advanced drugs.
  • Besides, increasing research & development activities to advance pharmaceutical products and find curative therapies for unknown diseases are contributing to the growth of Australia regenerative medicine market.
  • In this report, Australia regenerative medicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Shriners Children's Opens Build-A-Bear Foundation Buddy Rooms at Locations throughout North America

Retrieved on: 
Thursday, September 29, 2022
Health, Safety, Child, Hospital, NYSE, Build-A-Bear Workshop, Cleft lip and cleft palate, Spinal cord injury, Hope, Organization, Sports medicine, Creativity, Life, Patient, History, Burns, Palate, Burn, BBW, Shriners Hospitals for Children, Heart, Comfort, Bears' Cave, Residential care, Health insurance, Pharmaceutical industry, Toy

GREENVILLE, S.C. , Sept. 29, 2022   /PRNewswire-PRWeb/ -- Shriners Children's and Build-A-Bear Foundation have joined forces to offer a one-of-a-kind experience to the patients at Shriners Children's, helping to provide hope and healing to children receiving care.

Key Points: 
  • Shriners Children's and Build-A-Bear Foundation have joined forces to offer a one-of-a-kind experience to the patients at Shriners Children's.
  • Build-A-Bear Foundation Buddy Rooms will be available at Shriners Children's locations throughout North America for patients and families to pick out a complimentary furry friend and accessories.
  • Build-A-Bear Foundation Buddy Rooms will be available at Shriners Children's locations throughout North America for patients and families to pick out a complimentary furry friend and accessories.
  • To learn more about how to donate a furry friend to a Shriners Children's Build-A-Bear Foundation Buddy Room, visit lovetotherescue.org/build-a-bear-foundation-buddy-room .

ONWARD Announces Participation at Upcoming Events in October

Retrieved on: 
Thursday, September 29, 2022
Science, Neurology, Biotechnology, Research, Physical Therapy, Health, Medical Devices, Health Technology, Health, Marver, Movement, High Tech Campus Eindhoven, U.S. FDA, Spinal cord, Spinal cord injury, Nature, Company, CEO, Technology, Quality of life, Science, ARC, Medical device, Risk management

ONWARD is a medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injuries.

Key Points: 
  • ONWARD is a medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injuries.
  • ONWARD has received three Breakthrough Device Designations from the U.S. FDA encompassing both ARC-IMand ARC-EX.
  • These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein.
  • You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

United Spinal Strengthens Access to Employment Resources for People with Spinal Cord injuries and Disorders

Retrieved on: 
Wednesday, September 28, 2022
Pathway, Employment, Disability, Americans with Disabilities Act of 1990, Spinal cord injury, City, TBA, Program, Veteran, Air Carrier Access Act, Diagnosis, Bureau of Labor Statistics, SCI/D, Multimedia, Mentorship, Health insurance, United Spinal Association

The goal of the Pathways to Employment is to address this disparity by providingpeople with SCI/D access to a job portal, resources on benefits and transitioning to employment,how-to guides covering a variety of disability employment topics, and mentors who have successfully returned to work after spinal cord injury or diagnosis.

Key Points: 
  • The goal of the Pathways to Employment is to address this disparity by providingpeople with SCI/D access to a job portal, resources on benefits and transitioning to employment,how-to guides covering a variety of disability employment topics, and mentors who have successfully returned to work after spinal cord injury or diagnosis.
  • The program also supports employers in establishing an inclusive work environment by offering guidance onrecruitment, onboarding, and accommodations, and distributing job opportunities through United Spinal's national chapter network.
  • Formed in 1946 by paralyzed veterans, United Spinal is a national 501(c)(3) nonprofit membership organization dedicated to empowering people with spinal cord injuries and disorders (SCI/D), including veterans, to live successful and fulfilling lives.
  • Membership is free and open to all individuals with SCI/D, with over 60,000 members across 49 chapters, close to 200 support groups and more than 100 rehabilitation facilities and hospital partners nationwide.

Magnetic Resonance Imaging Market to Surpass Value of US$ 10.6 Bn by 2031: TMR Study

Retrieved on: 
Wednesday, September 28, 2022
TMR, Adoption, Incidence, Ageing, Prevalence, Hitachi, Elective surgery, Neoplasm, MRI, Population, Embrace Neonatal MRI System, Growth, Spine, Hand, Patient, Investment, Claustrophobia, Pediatrics, Google Images, Spinal cord injury, Diagnosis, Magnetic resonance imaging, US, GE Healthcare, Lists of countries and territories, Conditional sentence, Medical imaging, Medtech

The analysts opine that development of MRI systems that are suitable for claustrophobic and obese patients presents value-grab opportunities for medtech companies in magnetic resonance imaging market.

Key Points: 
  • The analysts opine that development of MRI systems that are suitable for claustrophobic and obese patients presents value-grab opportunities for medtech companies in magnetic resonance imaging market.
  • Rise in demand for magnetic resonance imaging (MRI) procedures in elderly population is a key market driver, observed the TMR study.
  • Continuous research and development of imaging equipment with emphasis on patient comfort has extended horizon for investments in the magnetic resonance imaging market.
  • Medtech companies in magnetic resonance imaging market are leaning on leveraging the synergies of strategic partnerships with diagnostic imaging services providers.

Magnetic Resonance Imaging Market to Surpass Value of US$ 10.6 Bn by 2031: TMR Study

Retrieved on: 
Wednesday, September 28, 2022
TMR, Adoption, Incidence, Ageing, Prevalence, Hitachi, Elective surgery, Neoplasm, MRI, Population, Embrace Neonatal MRI System, Growth, Spine, Hand, Patient, Investment, Claustrophobia, Pediatrics, Google Images, Spinal cord injury, Diagnosis, Magnetic resonance imaging, US, GE Healthcare, Lists of countries and territories, Conditional sentence, Medical imaging, Medtech

The analysts opine that development of MRI systems that are suitable for claustrophobic and obese patients presents value-grab opportunities for medtech companies in magnetic resonance imaging market.

Key Points: 
  • The analysts opine that development of MRI systems that are suitable for claustrophobic and obese patients presents value-grab opportunities for medtech companies in magnetic resonance imaging market.
  • Rise in demand for magnetic resonance imaging (MRI) procedures in elderly population is a key market driver, observed the TMR study.
  • Continuous research and development of imaging equipment with emphasis on patient comfort has extended horizon for investments in the magnetic resonance imaging market.
  • Medtech companies in magnetic resonance imaging market are leaning on leveraging the synergies of strategic partnerships with diagnostic imaging services providers.

BioCircuit Technologies, Inc. Closes a $9 million Series Seed Round

Retrieved on: 
Tuesday, September 27, 2022
Gait, FDA, Spinal cord injury, Stroke, Patient, CEO, GLOBE, NIH, Risk management, Pharmaceutical industry

Atlanta, GA, Sept. 27, 2022 (GLOBE NEWSWIRE) -- BioCircuit Technologies , a medical device company focused on peripheral nerve repair and neuromodulation, announces the close of a $9 million round of financing.

Key Points: 
  • Atlanta, GA, Sept. 27, 2022 (GLOBE NEWSWIRE) -- BioCircuit Technologies , a medical device company focused on peripheral nerve repair and neuromodulation, announces the close of a $9 million round of financing.
  • Funds from this round will be used to commercialize BioCircuits nerve repair device, Nerve Tape .
  • Based in Atlanta, GA, BioCircuit Technologies develops and commercializes medical devices for tissue repair and neuromodulation.
  • BioCircuit has received $7+ million in funding from numerous NIH grants and including this round, has attracted a total of $13.5+ million in private financing.

ONWARD Reports First Half 2022 Financial and Operating Results

Retrieved on: 
Tuesday, September 27, 2022
Biotechnology, Health, Surgery, Medical Devices, Income, Health, European Innovation Council, Movement, High Tech Campus Eindhoven, U.S. FDA, Spinal cord, McKinsey & Company, Spinal cord injury, Hemiunu, EDT, State Administrative Expenses, News, Nature, Company, Public, SCI, Patient, Government, Investment, Business, Forward-looking statement, Technology, SME, Quality of life, CLA, General officer, University of Virginia Darden School of Business, CET, Science, ARC, Marketing, RVO, University, Webcast, Medical device, Film, Bank, Pharmaceutical industry, EU, EUR, Euronext

Total Operating Expenses increased during H1 2022 by EUR 6,3 million to EUR 16,1 million.

Key Points: 
  • Total Operating Expenses increased during H1 2022 by EUR 6,3 million to EUR 16,1 million.
  • The decrease in cash of EUR 12,6 million compared to 31 December 2021 is due to cash outflows mainly for operating activities.
  • ONWARDs management expects to continue the steady and consistent execution of its strategy in the second half of 2022 and beyond.
  • Also in the second half of 2022, the Company expects to release combined top-line data from the STIMO-HEMO and HemON studies.

ONWARD Announces Appointment of Vivian Riefberg to Board of Directors

Retrieved on: 
Monday, September 26, 2022
Biotechnology, Health, Surgery, Medical Devices, Dutch public broadcasting system, Movement, McKinsey & Company, PBS, Nature, Public, Harvard Business School, Industry, Business, Davos, Government, Technology, University of Virginia Darden School of Business, Leadership, ARC, NIH, Child, U.S. FDA, Spinal cord injury, PHA, Financial compensation, Company, Obesity, Intellectual property, History, High Tech Campus Eindhoven, Science, Partnership, Spinal cord, First Lady Michelle Obama (painting), Radcliffe College, Forward-looking statement, Board of directors, Board, Health, American, Publication, Johns Hopkins School of Medicine, Quality of life, Solution, Uncertainty, Darden, World Economic Forum, Multimedia, University, Euronext, Management, Pharmaceutical industry, Medical device

ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced the appointment of Vivian Riefberg as a non-executive member of its Board of Directors.

Key Points: 
  • ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced the appointment of Vivian Riefberg as a non-executive member of its Board of Directors.
  • Her appointment to the Board will be presented for shareholder approval at the next Annual General Meeting.
  • View the full release here: https://www.businesswire.com/news/home/20220926005494/en/
    Vivian Riefberg joins the ONWARD Medical Board of Directors (Photo: Business Wire)
    Vivian Riefberg is a distinguished expert in health care, government, and strategy.
  • ONWARD has the opportunity to build a very special enterprise that is both successful and impactful, said Vivian Riefberg.